scholarly journals Clinical course involving thrombocytosis and thrombocytopenia in a patient with bladder cancer treated with gemcitabine and cisplatin

2021 ◽  
Vol 9 (12) ◽  
Author(s):  
Ayako Watanabe ◽  
Kenji Momo ◽  
Katsumi Tanaka ◽  
Takuya Nagata ◽  
Remi Kuchira ◽  
...  
2017 ◽  
Vol 197 (4S) ◽  
Author(s):  
Yuki Kita ◽  
Takashi Kobayashi ◽  
Atsuro Sawada ◽  
Ryouichi Saito ◽  
Toshinari Yamasaki ◽  
...  

2018 ◽  
Vol 199 (6) ◽  
pp. 1452-1458 ◽  
Author(s):  
Homayoun Zargar ◽  
Jay B. Shah ◽  
Bas W. van Rhijn ◽  
Siamak Daneshmand ◽  
Trinity J. Bivalacqua ◽  
...  

2011 ◽  
Vol 139 (9-10) ◽  
pp. 693-699 ◽  
Author(s):  
Ivan Damjanov ◽  
Mileta Golubovic

Bladder cancer is a common form of neoplasia which most often presents histologically as urothelial (transitional cell) carcinoma. In this article we review recent publications dealing with the less common variants of urothelial carcinoma such as tumours that show unusual forms of differentiation or the well know squamous, glandular, or sarcomatoid differentiation. Urothelial tumours may also show several distinct growth variants characterized by a nested, micropapillary, lymphoepithelioma-like, or plasmacytoid and giant cell growth pattern. The clinical course of bladder cancer varies depending on the histological type of neoplasia, grade and stage of the tumour. High-grade muscle-invasive urothelial cancers and tumours showing variant microscopic morphology have in general high mortality and poor prognosis.


Sign in / Sign up

Export Citation Format

Share Document